Procter & Gamble Chief Financial Officer Sold Shares Worth Over $5.5M

Procter & Gamble CFO Andre Schulten sold 33,624 shares at $165 each, totaling $5.55M. He now directly owns 65,618 shares and indirectly owns 7,604 shares via a retirement plan trust.

Original reporting
Published Nov 5, 2026, 2:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 2:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Procter & Gamble Chief Financial Officer Sold Shares Worth Over $5.5M — source image
Decision brief

The 30-second read

$PGBearishLow
01

Why it matters

The transaction is the first public report of this insider activity, providing new information to the market.

02

Market read

First-report insider sale of $5.5M by PG CFO, modestly bearish for the stock.

03

What to watch

Potential tax planning or diversification motives may drive the sale, not company fundamentals.

Relevance 6/10Novelty 6/10Timing: after-hours filing

Background

Form 4 filing disclosed the CFO's share sale, a standard regulatory disclosure for insider transactions.

Company-level read

Ticker impact

$PGBearishMedium confidence
Context

CFO Andre Schulten sold 33,624 shares of PG at $165, totaling $5.55M, reducing his direct holdings.

Expected impact

likely slight downward pressure as investors price in the CFO's sell.

Evidence & confidence

A $5.5M sale by the CFO is material for a large-cap consumer staple; such insider transactions often lead to short-term price softness.

Market effects

Minimal impact on consumer staples sector; peers unlikely to be affected.

U.S. market only; no regional ripple.

Low; limited to PG investors.

Counterpoint

The sale could be a routine portfolio rebalancing, not a bearish signal.

Key entities

  • Andre Schulten

    Chief Financial Officer of Procter & Gamble

Related articles

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of $750,000,000 aggregate principal amount of 5.125% Notes due October 30, 2031…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On October 30, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 5.125% Notes due October 30, 2031, $750,000,000 aggregate principal amount of 5.300% Notes due October 30